 |
June 17, 2005
University of Tennessee Health Sciences Center
Presenters included experts from the CDC, Emory University, Tennessee Department of Health, University of Tennessee, St. Jude Children’s Research Center, Wyeth Vaccines Research, and Merck Vaccine Division. The conference improved the community’s understanding of reasons for recent shortages of vaccines, explained state and federal roles for responding to shortages, identified critical issues affecting vaccine development and production, and shared new technological breakthroughs.
Objectives:
- Share reasons for recent shortages of vaccines
- Explain State and Federal roles for responding to shortages
- Identify critical issues affecting vaccine development and production
- Share new technological breakthroughs
Watch video from the conference.
 |
 |
Agenda |
|
|
Speaker Bios |
|
|
Transcript |
|
 |
Innovative Means for Pre-Clinical Testing of Vaccines, Malak Kotb, PhD |
|
|
Novel Approaches for Rapid Vaccine Development, Richard Webby, PhD |
|
|
Quick Response to Emerging Strains, Robert G. Webster, PhD |
|
|
Rewards, Penalties, Hurdles & Barriers, To Be or Not to Be a Vaccine Company, Alan Shaw, PhD |
|
|
The Role of Federal Agencies in Responding to Vaccine Shortages, Jeanne M. Santoli, MD, MPH |
|
|
Role of State Health Department in Responding to Vaccine Shortage Allen S. Craig, MD |
|
|
Use of Adjuvants to Enhance Vaccine Immunogenicity, Mark A. Miller, PhD |
|
|
Vaccine Shortages: R&D Challenges and Possible Solutions, William C. Gruber, MD |
|
|
Vaccine Supply: The Best of Times, The Worst of Times, Walter A. Orenstein, MD |
|
|
|
